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This study was carried out to determine the effects of polyphenols from cocoa powder on 
diabetic syndrome of obese-diabetic (Ob-db) rats. The studied diabetic syndrome are fasting 
plasma glucose level, oral glucose tolerance test, insulin level and insulin sensitivity, lipid 
profiles (total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density 
lipoprotein cholesterol, and free fatty acids), oxidative stress biomarker (8-isoprostane), and 
antioxidant enzymes (superoxide dismutase and catalase). Obese-diabetic (Ob-db) rats were 
developed using a high-fat diet (49% fat, 32% carbohydrate, and 19% protein from total 
energy, kcal) for 3 months, followed by a low dose (35 mg/kg body weight) streptozotocin 
(STZ) injection. Cocoa extract (600 mg/kg body weight) containing both polyphenols 
(2.17mg epicatechin, 1.52 mg catechin, 0.25 mg dimer and 0.13 mg trimer g/cocoa extract) 
and methylxanthines (3.55 mg caffeine and 2.22 mg theobromine g/cocoa extract) was given 
to the rats for 4 weeks. The results indicated that there were no significant differences in 
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fasting plasma glucose, insulin level and insulin sensitivity after 4 weeks of cocoa extracts 
administration. Oral glucose tolerance test revealed that cocoa supplementation in Ob-db rats 
significantly (p < 0.05) reduced plasma glucose at 60 and 90 min compared to 
unsupplemented Ob-db rats. The supplementation significantly (p < 0.05) reduced the plasma 
total cholesterol, triglycerides and low-density lipoprotein cholesterol of obese-diabetic rats 
(Ob-db + cocoa) compared with non-supplemented animals (Ob-db). Plasma free fatty acid 
and oxidative stress biomarker (8-isoprostane) were significantly (p < 0.05) reduced after 
cocoa supplementation. Superoxide dismutase activity was enhanced in Ob-db compared to 
that in non-supplemented rats. However, no change was observed in catalase activity. Cocoa 
supplementation had an effect on postprandial glucose control but not for long-term glucose 
control (4 weeks). Four weeks of cocoa extract supplementation also possess 
hypocholesterolaemic properties. Moreover, cocoa supplementation could reduce circulating 
plasma free fatty acid and 8 isoprostane and may enhance the antioxidant defense system. 
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Kajian ini dijalankan bagi menentukan kesan polifenol dari serbuk koko terhadap sindrom 
diabetik tikus obesiti-diabetik (Ob-db). Sindrom diabetik yang dikaji adalah paras glukosa 
plasma semasa puasa, ujian tolerans glukosa oral, paras insulin dan sensitiviti terhadap 
insulin, profit lipid (jumlah kolesterol, trigliserida, lipoprotein-kolesterol berketumpatan 
tinggi, dan lipoprotein-kolesterol berketumpatan rendah dan acid lemak bebas), penunjuk 
tekanan oksidatif (8-isoprostane), enzim antioksidan (superoksida dismutase dan katalase). 
Tikus obesiti-diabetik (Ob-db) dibangunkan dengan memberi diet tinggi lemak (49% lemak, 
32% karbohidrat, dan 19% protein daripada jumlah tenaga, kkal) selama 3 bulan, diikuti 
dengan suntikan streptozotocin (STZ) pada dos yang rendah (35 mg/kg berat badan). Ekstrak 
koko (600 mg/kg berat badan) yang mengandungi polifenol (2.17 mg epikatekin, 1.52 mg 
katekin, 0.25 mg dimer dan 0.13 mg trimer g/ekstrak koko) dan metilxantina (3.55 mg kafein 
dan 2.22 mg teobromina g/ekstrak koko) diberi selama 4 minggu. Keputusan menunjukkan 
v 
bahawa tiada kesan yang signifikan terhadap paras plasma glukosa puasa, paras insulin dan 
sensitiviti terhadap insulin selepas 4 minggu diberi ekstrak koko. Pemberian ekstrak koko 
pada tikus Ob-db menunjukkan penurunan glukosa pada minit 60 dan 90 yang signifikan di 
dalam ujian glukosa secara paksa jika dibandingkan dengan tikus Ob-db yang tidak diberi 
ekstrak koko. Pemberian itu juga menurunkan jumlah kolesterol plasma, trigliserida, dan 
lipoprotein-kolesterol berketumpatan rendah pada tahap yang signifikan (p < 0.05) terhadap 
tikus Ob-db jika dibandingkan dengan tikus yang tidak diberi ekstrak koko. Asid lemak bebas 
dan penunjuk tekanan oksidatif (8-isoprostane) menurun pada tahap yang signifikan (p 
<0.05) selepas pemberian ekstrak koko. Aktiviti enzim superokida dismutase diperkuatkan 
di dalam tikus Ob-db dibandingkan dengan tikus yang tidak diberi ekstrak koko. 
Walaubagaimanapun, tiada perubahan pada aktiviti enzim katalase. Keputusan menunjukkan 
pemberian koko mempunyai kesan terhadap kawalan glukosa selepas makan dan tidak untuk 
kawalan glukosa jangkamasa panjang (4 minggu). Pemberian ekstrak koko selama 4 minggu 
juga menunjukkan kesan hipokolesterolemia. Tambahan pula, pemberian koko boleh 
menurunkan asid lemak bebas dan 8-isoprostane dan dapat memperkuatkan sistem pertahanan 
antioksidan. 
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 
Background 
 
Nowadays, diabetes mellitus has become a major health problem affecting more 
than 171,000,000 people worldwide (WHO, 2008a). Globally, total number of 
people with diabetes for the year 2030, as described by World Health 
Organization (WHO) is likely to be 366,000,000. In Malaysia, the number of 
people with diabetes for the year 2000 is 942,000, and is expected to be 
2,479,000 in 2030 (WHO, 2008a). Generally, genetic, sedentary lifestyle, and 
obesity are factors directly related to diabetes. Specifically, it is well established 
that obesity and insulin resistance is a hallmark for the development of type 2 
diabetes mellitus (T2DM). Insulin resistance could be defined as clinical stage in 
which a normal or elevated insulin level produces an inadequate biological 
activity, and can be considered as a risk factor for metabolic syndrome and 
T2DM (Hunter and Garvey, 1998).  
 
Previous studies reported that many factors could exert the development of 
diabetes mellitus. According to Abou-Seif and Youssef (2004), oxidative stress 
is increased in both types of diabetes mellitus (Type 1 and 2), but the results 
were more pronounced in T2DM. A study also indicated that oxidative stress 
plays a major role in the development and progression of diabetes mellitus 
(Ferrari and Torres, 2003). Meigs et al. (2007) reported that there was a 
significant relationship between oxidative stress and insulin resistance. 
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Moreover, it has been reported that diabetic patients have significant defects in 
antioxidant protections that are important in the etiology of diabetic 
complications (Opara, 2002). Decreased in antioxidant defense such as 
superoxide dismutase (SOD), catalase (CAT), peroxidase (Px), ceruloplasmin 
(Cp) and glutathione peroxidase (GSH-Px) activities as well as a decrease in the 
GSH level and an increase in the concentration of glutathione disulfide (GSSG) 
were observed in erythrocytes of diabetic patients (Abou-Seif and Youssef, 
2004).  
 
The study on cocoa polyphenols became more extensive with the discovery of 
major low molecular weight polyphenols in cocoa and cocoa products, namely 
catechin, epicatechin, dimers epicatechin-(4β→8)-catechin (procyanidin B1), 
epicatechin-(4β→8)-epicatechin (procyanidin B2), and trimer [epicatechin- 
(4β→8)]2-epicatechin (procyanidin C1) (Thompson et al., 1972). Previous 
studies showed that monomeric polyphenols, namely epicatechin and catechin, 
dimer, trimer, and tetramer were detected by reverse-phase liquid 
chromatography mass spectometry (RP LC-MS) (Natsume et al., 2000). It is 
reported that flavonols (epicatechin and catechin) were predominant compounds 
in cocoa powder (Natsume et al., 2002). Recently, studies showed that chocolate 
is one of the most polyphenol-rich foods along with tea and wine (Arts et al., 
1999; Arts et al., 2000). 
 
Numerous studies have been reported on the health benefits of cocoa and their 
products on various types of diseases, namely, cardiovascular diseases, cancers, 
and diabetes (Wang et al., 2000; Osakabe et al., 2004; Taubert et al., 2007; Heiss 
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et al., 2005; Murphy et al., 2003; Amin et al. 2004; Bisson et al., 2007a; Bisson 
et al., 2008; Rozan et al., 2006).  
 
Tomaru et al. (2007) reported that cocoa liquor dose-dependently prevents the 
development of hyperglycemia in diabetic obese mice. To a greater extent, 
previous studies indicated that 4 weeks of cocoa powder extract supplementation 
to diabetic animal model showed hypolipidemic and hypoglycaemic properties 
(Ruzaidi et al., 2005; Ruzaidi et al., 2008). In human subjects with hypertension, 
dark chocolate administration ameliorated insulin (Grassi et al., 2005a; Grassi et 
al., 2005b). Brand-Miller et al. (2003) reported that incorporation of cocoa 
powder as flavour in different foods increased postprandial insulin secretion.  
 
Unlike cardiovascular diseases, there is still limited human study on the effects 
of cocoa polyphenols towards diabetes. More work is needed to explore the 
effects of cocoa polyphenols on diabetes risk. Currently, no other study has been 
carried out on the effects of cocoa extracts on diet-induced obese-diabetic (Ob-
db) rats. Therefore, this study was carried out to study the effects of cocoa 
extract prepared from Malaysian cocoa powder on biochemical parameters of 
obese-diabetic rats. 
 
 
Statement of Problem 
 
 
Recently, there is limited study done on diabetic-induced rats using combination 
of high-fat diet and a low dose of streptozotocin (STZ) that mimick human 
diabetes syndrome with regards to obesity and insulin resistance. In addition, 
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previous studies used beef and lard as a source of fat, which are relatively 
expensive compared to ghee (a type of fat produce from animal milk) and corn 
oil. Previous studies indicated that cocoa extracts prepared from cocoa powder 
and cocoa beans possessed hypoglycaemic and hypolipidemic properties in 
streptozotocin-induced diabetic rats (Amin et al., 2004; Ruzaidi et al., 2005; 
Tomaru et al., 2007; Ruzaidi et al., 2008). However, study on the effect of cocoa 
extracts on obese-diabetic (Ob-db) rats that imitate human diabetes syndrome is 
limited.  
 
Significance of Study 
 
This study aims to develop obese-diabetic (Ob-db) rats using a combination of 
high-fat diet and low-dose of streptozotocin injection. The cocoa extracts 
supplementation (4 weeks period) is able to improve biochemical parameters, 
namely, fasting plasma glucose, insulin level and sensitivity, and lipid profiles. 
Moreover, the supplementation is expected to reduce oxidative stress biomarker 
and improve antioxidant enzymes regulation. The results from this study will 
also be used in future to determine the underlying mechanisms of the observed 
effects.  
 
The growing numbers of functional foods is an area of interest owing to their 
significant health benefits. Recently in Japan, almost 49 Food for Specified 
Health Use (FOSHU) have been approved specifically for diabetes. In Malaysia, 
medicinal and complementary therapy (MCT) was established in selected 
government hospital as an alternative to conventional medicine. The 
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aforementioned situations showed that there is markedly increase in the need of 
functional foods as an adjunct for management of diabetes. 
 
Objectives of Study 
 
General Objective 
To determine the effect of cocoa extracts on biochemical parameters in obese 
diabetic (Ob-db) rats. 
 
 
Specific Objectives 
 
 
1) To develop obese-diabetic (Ob-db) rats using combination of high-fat 
diet (49% fat, 32% carbohydrate, and 19% protein from total energy, 
kcal) and low-dose (35 mg/ kg body weight) of streptozotocin injection. 
  
2) To determine the effect of cocoa extracts on glucometabolism (fasting 
plasma glucose, insulin level, insulin sensitivity, and oral glucose 
tolerance test) parameters in obese-diabetic (Ob-db) rats. 
 
3) To determine the effect of cocoa extracts on lipid profiles (total 
cholesterol, total triglycerides, low-density lipoprotein-cholesterol, high-
density lipoprotein cholesterol) and oxidative stress biomarker (8-
isoprostane) in obese-diabetic (Ob-db) rats. 
 
4) To determine the effect of cocoa extracts on antioxidant enzymes 
(superoxide dismutase and catalase) in obese-diabetic (Ob-db) rats. 
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
 
 
 
Diabetes Mellitus 
 
The prevalence of diabetes worldwide is at an alarming state. In year 2000, the 
estimated prevalence of diabetes for all age-groups was 2.8% and the prevalence 
was expected to increase to 4.4% in 2030 (Wild et al., 2004). Countries with the 
highest diabetes prevalence among the adult population are Nauru 
(30.7%), United Arab Emirates (19.5%), Saudi Arabia (16.7%), Bahrain 
(15.2%), and Kuwait (14.4%) (IDF, 2008a). Men showed higher prevalence of 
diabetes, but increasingly more women are having diabetes. The increased in 
prevalence of diabetes is most likely due to ageing population, unhealthy diet, 
overweight and obesity and sedentary lifestyle (IDF, 2008b). 
 
The total number of people with diabetes was 171 million in 2000 and is 
projected to be 366,000,000 in 2030 (Wild et al., 2004). Up to date, 5 countries 
with the largest numbers of people with diabetes are India (40.9 million), China 
(39.8 million), the United States (19.2 million), Russia (9.6 million) 
and Germany (7.4 million) (IDF, 2008a). In Malaysia, the number of people with 
diabetes in 2000 is 942,000 and is expected to be 2,479,000 in 2030 (WHO, 
2008a).  
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In the year 2000, the excess global mortality attributable to diabetes was 
estimated to be 2.9 million deaths, equivalent to 5.2% of all deaths (Roglic et al., 
2005). Poorest countries showed 2-3% of deaths attributable to diabetes and over 
8% in the United States, Canada, and the Middle East. Between the ages of 35-
64 years old, 6-27% of deaths are attributable to diabetes. Unfortunately, no 
available data on the mortality that was associated with diabetes in Malaysia. 
   
The global mortality rate due to diabetes presents a high burden to individual, 
community, and government. It can be classified into direct medical (healthcare 
cost) and indirect productivity-related costs (disability and premature mortality) 
attributable to diabetes. In the United States, direct and indirect medical 
expenditures related to diabetes were 132 billion US Dollars (Hogan et al., 
2003). However, the costs of diabetes are varied from one country to another, 
depending on the direct medical cost (hospital services, physician services, and 
medicines consumed by people with diabetes) and indirect cost (lost workdays, 
restricted activity days, prevalence of permanent disability, and mortality 
attributable to diabetes) (Hogan et al., 2003; Dawson et al., 2002).  
 
 
Definition, Diagnosis, and Classification of Diabetes Mellitus 
 
 
Diabetes comes from a Greek word which means "to siphon". Polyuria 
(excessive urination) is the commonest symptom of diabetes. Excessive water 
comes out of the body of a person as if it were being siphoned from the mouth 
through the urinary system out of the body (Medopedia, 2008). Mellitus is a 
Latin word that means "sweet like honey" (Merriam-Webmaster, 2008). Due to 
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high level of sugar in urine it is call Mellitus. In 600  
BC, two Indian physicians, Chakrata and Susruta differentiated the two forms as 
disease although the description relate to what we know today as type 1 diabetes. 
Later during the eighteenth and nineteenth centuries, it was identified as less 
clinically asymptomatic, which is marked glycosuria, often detected in later life, 
and commonly associated with overweight (WHO, 2008b). It is also described as 
a metabolic disorder of multiple aetiology characterized by chronic 
hyperglycaemia with disturbances of carbohydrate, fat, and protein metabolisms 
resulting from defects in insulin secretion, insulin action, or both (WHO, 2008b). 
 
Nowadays, the diagnosis of diabetes mellitus is followed according to WHO 
(1999). The diagnosis criteria was made based on the values of venous or 
capillary blood glucose (mmol/l or mg/dl) (Table 1.1). Diabetes mellitus can be 
classified into the aetiology of disorders of glycaemia, as depicted in Tables 1.2 
and 1.3. 
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Table 1.1. Values for Diagnosis of Diabetes and Other Categories of Hyperglycaemia 
 
 Glucose concentration, mmol/l (mg/dl) 
                
                       Whole blood                                                         Plasma 
          Venous                      Capillary                           Venous                  Capillary     
Diabetes mellitus:     
Fasting or ≥ 6.1 (≥ 110) ≥ 6.1 (≥ 110) ≥ 7.0 (≥ 126) ≥ 7.0 (≥ 126) 
2-hr post glucose load ≥ 10.0 (≥ 180) ≥ 11.1 (≥ 200) ≥ 11.1 (≥ 200) ≥ 12.2 (≥ 220) 
Impaired Glucose Tolerance:     
Fasting (if measured) and < 6.1 (< 110) and < 6.1 (< 110) and < 7.0 (< 126) and < 7.0 (< 126) and 
2-hr post glucose load ≥ 6.7 (≥ 120) ≥ 7.8 (≥ 140) ≥ 7.8 (≥ 140) ≥ 8.9 (≥ 160) 
Impaired Fasting Glycaemia (IFG)     
Fasting  ≥ 5.6 (≥ 100) and ≥ 5.6 (≥ 100) and ≥ 6.1 (≥ 110) and ≥ 6.1 (≥ 110) and 
 < 6.1 (< 110) < 6.1 (< 110) < 7.0 (< 126) < 7.0 (< 126) 
and (if measured)     
2-hr post glucose load < 6.7 (< 120) < 7.8 (< 140) < 7.8 (< 140) < 8.9 (< 160) 
 
 
Source: WHO (1999) 
 
Note: For epidemiological or population screening purposes, the fasting or 2-h value after 75 g oral glucose may be used alone. For 
clinical purpose, the diagnosis should always be confirmed by repeating the test on another day unless there in unequivocal 
hyperglycaemia with acute metabolic decompensation or obvious symptoms. 
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Table 1.2. Aetiological Classification of Disorders of Glycaemia 
 
Type 1 Beta-cell destruction, usually leading to absolute insulin 
deficiency 
 -Autoimmune 
 
 -Idiopathic 
 
Type 2 May range from predominantly insulin resistance with 
relative insulin deficiency to a predominantly secretory 
defect with or without insulin resistance 
 
Other specific types 
(see table 1.3) 
-Genetic defects of beta-cell function 
 
 -Genetic defects in insulin action 
 
 -Diseases of the exocrine pancreas 
 
 -Endocrinopathies 
 
 -Drug- or chemical-induced 
 
 -Uncommon forms of immune-mediated diabetes 
 
 -Other genetic syndromes sometimes associated with 
diabetes 
 
 
Source: WHO (1999) 
 
 
Note:  Asterisk (*) includes the former categories of gestational 
impaired glucose tolerance and gestational diabetes 
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Table 1.3. Other Specific Types of Diabetes Mellitus 
 
 
 
Specific Types of Diabetes 
 
 
Causes of diabetes 
Genetic defects of β-cell 
function 
Chromosome 20, HNF 2α (MODY 1) 
 Chromosome 7, Glucokinase 
(MODY 2) 
 Chromosome 12, HNF 1α (MODY 3) 
 Chromosome 13, IPF-1 (MODY 4) 
 Mitochondria DNA 3243 mutation  
  
Genetic Defects in Insulin 
Action 
Type A insulin resistance 
 Leprechaunism 
 Rabson-Mendenhall syndrome 
 Lipoatrophic diabetes 
  
Disease of The Exocrine 
Pancreas 
Fibrocalculous pancreatopathy 
 Pancreatitis 
 Trauma/pancreatectomy 
 Neoplasia 
 Cystic fibrosis 
 Haemochromatosis 
  
Endocrinopathies Cushing’s syndrome 
 Acromegaly 
 Phaeochromocytoma 
 Glucagonoma 
 Hyperthyroidism 
 Somatostatinoma 
  
Infections Congenital rubella 
 Cytomegalovirus 
  
Uncommon form of Immune-
mediated Diabetes 
Insulin autoimmune syndrome 
(antibodies to insulin) 
 Anti-insulin receptor antibodies 
 “Stiff Man” syndrome 
 
Source: WHO (1999) 
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Risk Factors 
 
 
Family History 
 
Family history has been demonstrated to play a role in the development of 
diabetes mellitus. Silva et al. (2005) showed that insulin sensitivity and clearance 
was lower in white children with family history of diabetes mellitus compared to 
children without family history of diabetes mellitus. In African-American 
children, Kapriel et al. (1999) showed that family history of T2DM is a risk 
factor for insulin resistance. The important metabolic alterations are impaired 
insulin-stimulated total and nonoxidative glucose disposal early in the first 
decade of life. These studies showed that children with family history of diabetes 
had higher BMI and body fat distribution. Cruz et al. (2002) support the 
hypothesis in which specific accumulation of visceral fat in addition to overall 
adiposity in Hispanic children increases the risk of type 2 diabetes. Among 
Japanese-Americans population, women with family history showed a 
significantly higher incidence of T2DM compared to those without family 
history of diabetes. However, no significant result was observed for men. The 
result suggested that in Japanese people living in America increased westernised 
lifestyle, family history of diabetes still predict the incidence of T2DM 
especially among women (Nakanishi et al., 2003).  
  
In a cross-sectional study of 3,068 men and women, aged between 20–65 years 
and without known diabetes, Van Dam et al. (2001) indicated that those with 
family history of diabetes had larger waist circumference and fasting plasma 
glucose. Moreover, the association between abdominal obesity and 
